Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

PTEN mutation predicts unfavorable fertility preserving treatment outcome in the young patients with endometrioid endometrial cancer and atypical hyperplasia.

Journal of gynecologic oncology - 1 Jul 2023

Xue Yu, Dong Youting, Lou Yaochen, Lv Qiaoying, Shan Weiwei, Wang Chao, Chen Xiaojun

Abstract excerpt

OBJECTIVE: This study aimed to investigate the impact of molecular classification and PTEN, KRAS and PIK3CA gene mutation on the outcome of fertility-preserving treatment in the patients with endometrioid endometrial cancer (EEC) and endometrial atypical hyperplasia (EAH). METHODS: This is a single-center retrospective study. A total of 135 patients with EEC and EAH receiving fertility-preserving treatment and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma, Endometrioid
Share to Class I Phosphatidylinositol 3-Kinases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Endometrial Hyperplasia

Share to Endometrial Neoplasms

Share to Fertility

Share to Hyperplasia

Share to Proto-Oncogene Proteins p21(ras)

Share to PTEN Phosphohydrolase

Source

Open in PubMed Open full text

Identifiers

PMID: 36929579
DOI: 10.3802/jgo.2023.34.e53
PMCID: PMC10323299

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

PTEN mutation predicts unfavorable fertility preserving treatment outcome in the young patients with endometrioid endometrial cancer and atypical hyperplasia.PMID 36929579Read ↗

Outcomes of fertility preservation treatments in patients with endometrial cancer with different molecular classifications based on an NGS panelSemantic proximity Read ↗

Mismatch repair status influences response to fertility-sparing treatment of endometrial cancer.Semantic proximity Read ↗

Efficacy of fertility-sparing treatment with LNG-IUS is associated with different ProMisE subtypes of endometrial carcinoma or atypical endometrial hyperplasia.Semantic proximity Read ↗

Potential of molecular classification to guide fertility-sparing management among young patients with endometrial cancer.Semantic proximity Read ↗

Prognostic Analysis of PTEN Mutation in Endometrial CarcinomaSemantic proximity Read ↗

Analysis of fertility-preserving treatment outcomes in patients with POLE-mutated endometrioid carcinoma.Semantic proximity Read ↗

The Advance and Correlation of KRAS Mutation With the Fertility-Preservation Treatment of Endometrial Cancer in the Background of Molecular Classification Application.Semantic proximity Read ↗

The Molecular Biology of Endometrial Cancers and the Implications for Pathogenesis, Classification, and Targeted TherapiesSemantic proximity Read ↗

Significance of PTEN Mutational Status Associated Gene Signature in the Progression and Prognosis of Endometrial CarcinomaSemantic proximity Read ↗

Molecular subtyping in endometrial cancer: A promising strategy to guide fertility preservationSemantic proximity Read ↗

Clinical features of ProMisE groups identify different phenotypes of patients with endometrial cancer.Semantic proximity Read ↗

Identification of a Gene Panel for Endometrioid Endometrial Cancer: a Possible Prognostic Value?Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.